1
|
Ou J, Zheng L, Chen Y, Fu Q, Tan L, Liang E, Huang L, Pan Y, Ke J, Chen Z, Cheng K. Heterocyclic-Modified Imidazoquinoline Derivatives: Selective TLR7 Agonist Regulates Tumor Microenvironment against Melanoma. J Med Chem 2024; 67:3321-3338. [PMID: 38363069 DOI: 10.1021/acs.jmedchem.3c01504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/17/2024]
Abstract
Immunotherapy targeting the toll-like receptor 7 (TLR7) is a promising strategy for cancer treatment. Herein, we describe the design and synthesis of a series of imidazoquinoline-based TLR7 agonists and assess NF-κB pathway activation using HEK-Blue hTLR7 cells to identify the most potent small-molecule TLR7 agonist, SMU-L11 (EC50 = 0.024 ± 0.002 μM). In vitro experiments demonstrated that SMU-L11 specifically activated TLR7, resulting in recruitment of the MyD88 adaptor protein and activation of the NF-κB and MAPK signaling pathways. Moreover, SMU-L11 was found to exert immune-enhancing effects by significantly inducing the secretion of proinflammatory cytokines in murine dendritic cells, macrophages, and human peripheral blood mononuclear cells while promoting M1 macrophage polarization. In vivo studies using a B16-F10 mouse tumor model showed that SMU-L11 significantly enhanced immune cell activation and augmented CD4+ T and CD8+ T-cell proliferation, directly killing tumor cells and inhibiting tumor growth.
Collapse
Affiliation(s)
- Jiaxin Ou
- Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Lu Zheng
- Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Yanlin Chen
- Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Qiuyue Fu
- Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Liyi Tan
- Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - En Liang
- Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Lan Huang
- Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Yue Pan
- Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Jiahua Ke
- Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Zhipeng Chen
- Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Kui Cheng
- Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| |
Collapse
|
2
|
He KJ, Gong G, Liang E, Lv Y, Lin S, Xu J. Pan-cancer analysis of 60S Ribosomal Protein L7-Like 1 (RPL7L1) and validation in liver hepatocellular carcinoma. Transl Oncol 2024; 40:101844. [PMID: 38042135 PMCID: PMC10701367 DOI: 10.1016/j.tranon.2023.101844] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Revised: 11/04/2023] [Accepted: 11/21/2023] [Indexed: 12/04/2023] Open
Abstract
BACKGROUND AND AIMS There is an association between cancer and increased ribosome biogenesis. At present, the RPL7L1 (60S Ribosomal Protein L7-Like 1) were less reported by literature search. Study reports that RPL7L1 is associated with mouse embryonic and skeletal muscle. The study of RPL7L1 on tumors has not been reported. METHODS Our team downloaded the pan-cancer dataset that is uniformly normalized from the UCSC database (N=19131). Our study examined the relationship between RPL7L1 expression level and clinical prognosis with methylation, anti-tumour immunity, functional states, MSI, TMB, DNSss, LOH and chemotherapeutic responses in 43 cancer types and subtypes. RESULTS AND CONCLUSIONS RPL7L1 was overexpressed in nine tumor types. Gene mutation, tumor microenvironment and methylation modification of RPL7L1 plays a key role in patient prognosis. And the high expression of RPL7L1 was associated with TMB, MSI, LOH especially LIHC and HNSC. We experimentally verified that genes can promote the proliferation and migration of tumor cells. Our study suggested that RPL7L1 biomarker can be used for treating cancer, detecting it, and predicting its prognosis.
Collapse
Affiliation(s)
- Ke-Jie He
- The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou city, Zhejiang Province, China.
| | - Guoyu Gong
- School of Medicine, Xiamen University, Xiamen China
| | - E Liang
- Xiamen Xianyue Hospital, Xiamen China
| | - Yangbo Lv
- The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou city, Zhejiang Province, China
| | - Shuiquan Lin
- The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou city, Zhejiang Province, China
| | - Jianguang Xu
- The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou city, Zhejiang Province, China.
| |
Collapse
|
3
|
Huang Y, Zhang L, Liu T, Liang E. LMNB1 targets FOXD1 to promote progression of prostate cancer. Exp Ther Med 2023; 26:513. [PMID: 37840569 PMCID: PMC10570766 DOI: 10.3892/etm.2023.12212] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2022] [Accepted: 06/09/2023] [Indexed: 10/17/2023] Open
Abstract
Forkhead box D1 (FOXD1) expression is upregulated in various types of human cancer. To the best of our knowledge, the roles of FOXD1 in prostate cancer (PC) remain largely unknown. The Cancer Genome Atlas dataset was used for the bioinformatics analysis of FOXD1 in PC. FOXD1 expression levels in normal immortalized human prostate epithelial cells (RWPE-1) and prostate cancer cells were detected by reverse transcription-quantitative PCR. PC cell viability was detected using Cell Counting Kit-8 assay. Transwell assays were performed to assess the migration and invasion of PC cells. Luciferase reporter gene assay was used to validate the association between FOXD1 and lamin (LMN)B1. LMNB1 is an important part of the cytoskeleton, which serves an important role in the process of tumor occurrence and development, regulating apoptosis and DNA repair. FOXD1 expression was upregulated in PC tissues, with its high expression being associated with clinical stage and survival in PC. Knockdown of FOXD1 inhibited viability, migration and invasion of PC cells. FOXD1 positively regulated LMNB1 expression. The effect of FOXD1 knockdown on PC cells was reversed by LMNB1 overexpression. In conclusion, FOXD1, positively regulated by LMNB1, served as an oncogene in PC and may be a potential biomarker and treatment target for PC.
Collapse
Affiliation(s)
- Yuanshe Huang
- Agriculture College, Innovation Center for Efficient Agricultural of Guizhou Mountain Characteristics, Anshun University, Anshun, Guizhou 561000, P.R. China
| | - Lai Zhang
- Agriculture College, Innovation Center for Efficient Agricultural of Guizhou Mountain Characteristics, Anshun University, Anshun, Guizhou 561000, P.R. China
| | - Tianlei Liu
- Agriculture College, Innovation Center for Efficient Agricultural of Guizhou Mountain Characteristics, Anshun University, Anshun, Guizhou 561000, P.R. China
| | - E Liang
- Agriculture College, Innovation Center for Efficient Agricultural of Guizhou Mountain Characteristics, Anshun University, Anshun, Guizhou 561000, P.R. China
| |
Collapse
|
4
|
Liang E, Xiao S, Zhao C, Zhang Y, Fu G. M6A modification promotes blood-brain barrier breakdown during cerebral ischemia/reperfusion injury through increasing matrix metalloproteinase 3 expression. Heliyon 2023; 9:e16905. [PMID: 37332938 PMCID: PMC10275791 DOI: 10.1016/j.heliyon.2023.e16905] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2022] [Revised: 04/26/2023] [Accepted: 05/31/2023] [Indexed: 06/20/2023] Open
Abstract
Blood-brain barrier (BBB) breakdown is a critical event in cerebral ischemia-reperfusion (I/R) injury, and matrix metalloproteinases (MMPs), which are proteolytic enzymes, play essential roles in BBB breakdown through degrading the extracellular matrix. N6-Methyladenosine (m6A), the most common and reversible mRNA modification, has an important role in the progression of cerebral I/R injury. However, whether m6A is related to BBB breakdown and MMPs expression in cerebral I/R injury is still not clear. In this study, we explored the potential effects of m6A modification on BBB breakdown in cerebral I/R injury and its underlying mechanisms using mice subjected to transient middle cerebral artery occlusion and reperfusion (MCAO/R), and mouse brain endothelial cells treated with oxygen-glucose deprivation and reoxygenation (OGD/R). We find that MMP3 expression is highly expressed and positively associated with the m6A writer CBLL1 (Cbl proto-oncogene like 1) in cerebral I/R injury in vivo and in vitro. Furthermore, MMP3 mRNA occurs m6A modification in mouse brain endothelial cells, and the m6A modification level of MMP3 mRNA is significantly increased in cerebral I/R injury. Moreover, inhibition of m6A modification reduces MMP3 expression and ameliorates BBB breakdown in cerebral I/R in vivo and in vitro. In conclusion, m6A modification promotes BBB breakdown in cerebral I/R injury through increasing MMP3 expression, indicating that m6A may be a potential therapeutic target for cerebral I/R injury.
Collapse
Affiliation(s)
- En Liang
- Department of Neurosurgery, Guangzhou PanYu He Xian Memorial Hospital, Guangzhou, 511442, PR China
| | - Shaorong Xiao
- Centre for Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou, 510006, PR China
| | - Changtong Zhao
- Department of Neurosurgery, Guangzhou PanYu He Xian Memorial Hospital, Guangzhou, 511442, PR China
| | - Yu Zhang
- Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, 518133, PR China
| | - Guanglei Fu
- Department of Neurology, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, PR China
| |
Collapse
|
5
|
Liang E, Wang Z, Li X, Wang S, Han X, Chen D, Zheng A. 3D Printing Technology Based on Versatile Gelatin-Carrageenan Gel System for Drug Formulations. Pharmaceutics 2023; 15:pharmaceutics15041218. [PMID: 37111703 PMCID: PMC10141357 DOI: 10.3390/pharmaceutics15041218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2023] [Revised: 03/27/2023] [Accepted: 04/03/2023] [Indexed: 04/29/2023] Open
Abstract
Currently, there is a shortage of pediatric medicines on the market, and 3D printing technology can more flexibly produce personalized medicines to meet individual needs. The study developed a child-friendly composite gel ink (carrageenan-gelatin), created 3D models by computer-aided design technology, then produced personalized medicines using 3D printing to improve the safety and accuracy of medication for pediatric patients. An in-depth understanding of the printability of different formulations was obtained by analyzing the rheological and textural properties of different gel inks and observing the microstructure of different gel inks, which guided the formulation optimization. Through formulation optimization, the printability and thermal stability of gel ink were improved, and F6 formulation (carrageenan: 0.65%; gelatin: 12%) was selected as the 3D printing inks. Additionally, a personalized dose linear model was established with the F6 formulation for the production of 3D printed personalized tablets. Moreover, the dissolution tests showed that the 3D printed tablets were able to dissolve more than 85% within 30 min and had similar dissolution profiles to the commercially available tablets. This study demonstrates that 3D printing is an effective manufacturing technique that allows for flexible, rapid, and automated production of personalized formulations.
Collapse
Affiliation(s)
- En Liang
- Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs, School of Pharmacy, Yantai University, Yantai 264005, China
- Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, Haidian District, Beijing 100850, China
| | - Zengming Wang
- Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, Haidian District, Beijing 100850, China
| | - Xiang Li
- Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, Haidian District, Beijing 100850, China
| | - Shanshan Wang
- Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, Haidian District, Beijing 100850, China
| | - Xiaolu Han
- Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, Haidian District, Beijing 100850, China
| | - Daquan Chen
- Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs, School of Pharmacy, Yantai University, Yantai 264005, China
| | - Aiping Zheng
- Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, Haidian District, Beijing 100850, China
| |
Collapse
|
6
|
Shi J, Zhao Z, Dai Y, He J, Li T, Liang E, Wang J, Ni G, Sheng C, Wu D, Zhou S, Chen L, Zhao H. Nonthermal Ultrafast Optical Control of Magnetization Dynamics by Linearly Polarized Light in Metallic Ferromagnet. Adv Sci (Weinh) 2023; 10:e2205903. [PMID: 36596707 PMCID: PMC9951311 DOI: 10.1002/advs.202205903] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/11/2022] [Revised: 11/27/2022] [Indexed: 06/17/2023]
Abstract
Coherent optical control of the magnetization in ferromagnetic (FM) mediums using ultrafast nonthermal effect paves a promising avenue to improve the speed and repetition rate of the magnetization manipulation. Whereas previously, only heat-induced or helicity-dependent magnetization dynamics are demonstrated in metallic ferromagnets. Here, the linearly-polarized light control of magnetization is demonstrated in FM Co coupled with ferroelectric (FE) BiFeO3 by tuning the light polarization direction. It is revealed that in the Co/BiFeO3 heterostructure excited by femtosecond laser pulses, the magnetization precession amplitude follows a sinusoidal dependence on the laser polarization direction. This nonthermal control of coherent magnetization rotation is attributed to the optical rectification effect in the BiFeO3 layer, which yields a FE polarization depending on the light polarization, and the subsequent modulation of magnetic energy in Co by the electrostriction-induced strain. This work demonstrates an effective route to nonthermally manipulate the ultrafast magnetization dynamics in metallic ferromagnets.
Collapse
Affiliation(s)
- Jingyu Shi
- Key Laboratory of Micro & Nano Photonic Structures (MOE)and Shanghai Ultra‐precision Optical Manufacturing Engineering Research CenterDepartment of Optical Science and EngineeringFudan UniversityShanghai200433China
- Basic Experimental Teaching CenterShaanxi Normal UniversityXi'an710062China
| | - Zirui Zhao
- Key Laboratory of Micro & Nano Photonic Structures (MOE)and Shanghai Ultra‐precision Optical Manufacturing Engineering Research CenterDepartment of Optical Science and EngineeringFudan UniversityShanghai200433China
| | - Yu Dai
- School of Physics Science and EngineeringTongji UniversityShanghai200092China
| | - Jiang He
- Key Laboratory of Micro & Nano Photonic Structures (MOE)and Shanghai Ultra‐precision Optical Manufacturing Engineering Research CenterDepartment of Optical Science and EngineeringFudan UniversityShanghai200433China
| | - Tao Li
- Key Laboratory of Micro & Nano Photonic Structures (MOE)and Shanghai Ultra‐precision Optical Manufacturing Engineering Research CenterDepartment of Optical Science and EngineeringFudan UniversityShanghai200433China
| | - En Liang
- Key Laboratory of Micro & Nano Photonic Structures (MOE)and Shanghai Ultra‐precision Optical Manufacturing Engineering Research CenterDepartment of Optical Science and EngineeringFudan UniversityShanghai200433China
| | - Jun Wang
- Key Laboratory of Micro & Nano Photonic Structures (MOE)and Shanghai Ultra‐precision Optical Manufacturing Engineering Research CenterDepartment of Optical Science and EngineeringFudan UniversityShanghai200433China
| | - Gang Ni
- Key Laboratory of Micro & Nano Photonic Structures (MOE)and Shanghai Ultra‐precision Optical Manufacturing Engineering Research CenterDepartment of Optical Science and EngineeringFudan UniversityShanghai200433China
| | - Chuanxiang Sheng
- Key Laboratory of Micro & Nano Photonic Structures (MOE)and Shanghai Ultra‐precision Optical Manufacturing Engineering Research CenterDepartment of Optical Science and EngineeringFudan UniversityShanghai200433China
| | - Di Wu
- National Laboratory of Solid State MicrostructuresDepartment of PhysicsNanjing UniversityNanjing210093China
| | - Shiming Zhou
- School of Physics Science and EngineeringTongji UniversityShanghai200092China
| | - Liangyao Chen
- Key Laboratory of Micro & Nano Photonic Structures (MOE)and Shanghai Ultra‐precision Optical Manufacturing Engineering Research CenterDepartment of Optical Science and EngineeringFudan UniversityShanghai200433China
| | - Haibin Zhao
- Key Laboratory of Micro & Nano Photonic Structures (MOE)and Shanghai Ultra‐precision Optical Manufacturing Engineering Research CenterDepartment of Optical Science and EngineeringFudan UniversityShanghai200433China
- Shanghai Frontiers Science Research Base of Intelligent Optoelectronics and PerceptionInstitute of OptoelectronicsFudan UniversityShanghai200433China
| |
Collapse
|
7
|
Smith E, Naik A, Krist D, Shaffer A, Liang E, Goel M, Smith R. A Comparison of Modalities to Differentiate Radiation Necrosis from Tumor Progression: A Diagnostic Meta-Analysis. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.860] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
8
|
Abstract
BACKGROUND Whether metformin is related to nonalcoholic fatty liver disease (NAFLD) is controversial. Our aim was to investigate the relationship between metformin and NAFLD that may predict the metformin potential of these lesions and new prevention strategies in NAFLD patients. METHODS The meta-analysis was analyzed by Revman 5.3 softwares systematically searched for works published through July 29, 2022. Network pharmacology research based on databases, Cytoscape 3.7.1 software and R software respectively. RESULTS The following variables were associated with metformin in NAFLD patients: decreased of alanine aminotransferase (ALT) level (mean difference [MD] = -10.84, 95% confidence interval [CI] = -21.85 to 0.16, P = .05); decreased of aspartate amino transferase (AST) level (MD = -4.82, 95% CI = -9.33 to -0.30, P = .04); decreased of triglyceride (TG) level (MD = -0.17, 95% CI = -0.26 to -0.08, P = .0002); decreased of total cholesterol (TC) level (MD = -0.29, 95% CI = -0.47 to -0.10, P = .003); decreased of insulin resistance (IR) level (MD = -0.42, 95% CI = -0.82 to -0.02, P = .04). In addition, body mass index (BMI) (MD = -0.65, 95% CI = -1.46 to 0.16, P = .12) had no association with metformin in NAFLD patients. 181 metformin targets and 868 NAFLD disease targets were interaction analyzed, 15 core targets of metformin for the treatment of NAFLD were obtained. The effect of metformin on NAFLD mainly related to cytoplasm and protein binding, NAFLD, hepatitis B, pathway in cancer, toll like receptor signaling pathway and type 2 diabetes mellitus (T2DM). The proteins of hypoxia inducible factor-1 (HIF1A), nuclear factor erythroid 2-related factor (NFE2L2), nitric oxide synthase 3 (NOS3), nuclear receptor subfamily 3 group C member 1 (NR3C1), PI3K catalytic subunit alpha (PIK3CA), and silencing information regulator 2 related enzyme 1 (SIRT1) may the core targets of metformin for the treatment of NAFLD. CONCLUSION Metformin might be a candidate drug for the treatment of NAFLD which exhibits therapeutic effect on NAFLD patients associated with ALT, AST, TG, TC and IR while was not correlated with BMI. HIF1A, NFE2L2, NOS3, NR3C1, PIK3CA, and SIRT1 might be core targets of metformin for the treatment of NAFLD.
Collapse
Affiliation(s)
- Yuanshe Huang
- AnShun University, Guizhou Anshun, China
- College of Pharmaceutical Sciences, Southwest University, Chongqing, China
| | - Xiaodong Wang
- Chongqing Medical and Pharmaceutical College, Chongqing, China
| | - Chen Yan
- An Shun City People’s Hospital, Anshun, China
| | - Chen Li
- Department of Biology, Chemistry, Pharmacy, Free University of Berlin, Berlin, Germany
| | - Lidan Zhang
- College of Pharmaceutical Sciences, Southwest University, Chongqing, China
| | - Lai Zhang
- AnShun University, Guizhou Anshun, China
| | - E Liang
- AnShun University, Guizhou Anshun, China
| | | | - Jingxin Mao
- College of Pharmaceutical Sciences, Southwest University, Chongqing, China
- Chongqing Medical and Pharmaceutical College, Chongqing, China
- *Correspondence: Jingxin Mao, Chongqing Medical and Pharmaceutical College, Chongqing 400030, China (e-mail: )
| |
Collapse
|
9
|
Higgins V, Nichols M, Gao H, Maravilla N, Liang E, Su J, Xu M, Rokhforooz F, Leung F. Defining blood gas analysis stability limits across five sample types. Clin Biochem 2022; 115:107-111. [PMID: 36126745 DOI: 10.1016/j.clinbiochem.2022.09.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2022] [Revised: 09/08/2022] [Accepted: 09/14/2022] [Indexed: 11/03/2022]
Abstract
Accurate reporting of blood gas samples is dependent upon following proper preanalytical sample handling requirements though there is variation for sample acceptability criteria across institutions. We examined five common sample types (arterial, venous, umbilical arterial, umbilical venous and capillary) stored at either room temperature or on crushed ice in a time series (0, 15, 30, 45, 60, 90, 180, 240 min) and applied local regulatory and/or institutional allowable performance limits to determine the need for cold preservation and/or maximum stability time for pH, pO2, pCO2, glucose, lactate, sodium, potassium, chloride, and ionized calcium where applicable in each sample type. Although changes in sample pO2 and/or lactate values were responsible, in part or in whole, for surpassing the allowable limits in nearly all sample types analyzed, this was not uniformly observed across sample types within the typical time limits that are referenced in literature. Furthermore, we demonstrated that cold preservation may not ubiquitously provide longer stability for blood gas specimens and this is dependent on the sample type and analyte in question. Nevertheless, these results demonstrate the known instability of pO2 and lactate and suggest that it may be possible to simplify the monitoring of preanalytical conditions by first evaluating pO2 and lactate in patient blood gas samples if applicable.
Collapse
Affiliation(s)
- V Higgins
- DynaLIFE Medical Labs, Edmonton, AB, Canada; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada
| | - M Nichols
- Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada; Department of Pathology and Laboratory Medicine, London Health Sciences Centre, Victoria Hospital, London, ON, Canada
| | - H Gao
- Department of Pathology and Laboratory Medicine, Sinai Health System, Toronto, ON, Canada
| | - N Maravilla
- Department of Pathology and Laboratory Medicine, Sinai Health System, Toronto, ON, Canada
| | - E Liang
- Department of Pathology and Laboratory Medicine, Sinai Health System, Toronto, ON, Canada
| | - J Su
- Department of Pathology and Laboratory Medicine, Sinai Health System, Toronto, ON, Canada
| | - M Xu
- Department of Pathology and Laboratory Medicine, Sinai Health System, Toronto, ON, Canada
| | - F Rokhforooz
- Department of Pathology and Laboratory Medicine, Sinai Health System, Toronto, ON, Canada
| | - F Leung
- Department of Pathology and Laboratory Medicine, Sinai Health System, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
| |
Collapse
|
10
|
Chen Z, Wang B, Liang Y, Shi L, Cen X, Zheng L, Liang E, Huang L, Cheng K. Near-Infrared Fluorescent and Photoacoustic Dual-Mode Probe for Highly Sensitive and Selective Imaging of Cysteine In Vivo. Anal Chem 2022; 94:10737-10744. [DOI: 10.1021/acs.analchem.2c01372] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Affiliation(s)
- Zhenzhou Chen
- Guangdong Provincial Key Laboratory of New Drug Screening and Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Baoqu Wang
- Guangdong Provincial Key Laboratory of New Drug Screening and Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Yuqing Liang
- Guangdong Provincial Key Laboratory of New Drug Screening and Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Liu Shi
- Guangdong Provincial Key Laboratory of New Drug Screening and Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Xiaohong Cen
- Guangdong Provincial Key Laboratory of New Drug Screening and Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Lu Zheng
- Guangdong Provincial Key Laboratory of New Drug Screening and Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - En Liang
- Guangdong Provincial Key Laboratory of New Drug Screening and Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Lan Huang
- Guangdong Provincial Key Laboratory of New Drug Screening and Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
| | - Kui Cheng
- Guangdong Provincial Key Laboratory of New Drug Screening and Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
- Department of Musculoskeletal Oncology, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510642, China
| |
Collapse
|
11
|
Liang E, Zheng KQ, Yao K, Lo W, Hasson H, Zhang A, Burns M, Wong WH, Zhang Y, Dashko A, Quevedo H, Ditmire T, Dyer G. A scintillator attenuation spectrometer for intense gamma-rays. Rev Sci Instrum 2022; 93:063103. [PMID: 35777994 DOI: 10.1063/5.0082131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
A new type of compact high-resolution high-sensitivity gamma-ray spectrometer for short-pulse intense gamma-rays (250 keV to 50 MeV) has been developed by combining the principles of scintillators and attenuation spectrometers. The first prototype of this scintillator attenuation spectrometer (SAS) was tested successfully in Trident laser experiments at LANL. Later versions have been used extensively in the Texas Petawatt laser experiments in Austin, TX, and more recently in OMEGA-EP laser experiments at LLE, Rochester, NY. The SAS is particularly useful for high-repetition-rate laser applications. Here, we give a concise description of the design principles, capabilities, and sample preliminary results of the SAS.
Collapse
Affiliation(s)
- E Liang
- Physics and Astronomy Department, Rice University, Houston, Texas 77005, USA
| | - K Q Zheng
- Physics and Astronomy Department, Rice University, Houston, Texas 77005, USA
| | - K Yao
- Division of Physics, Mathematics and Astronomy, California Institute of Technology, Pasadena, California 91125, USA
| | - W Lo
- Physics and Astronomy Department, Rice University, Houston, Texas 77005, USA
| | - H Hasson
- Physics Department, University of Rochester, Rochester, New York 14627, USA
| | - A Zhang
- Division of Physics, Mathematics and Astronomy, California Institute of Technology, Pasadena, California 91125, USA
| | - M Burns
- Physics and Astronomy Department, Rice University, Houston, Texas 77005, USA
| | - W H Wong
- M.D. Anderson Cancer Center, Diagnostic Imaging Division, Houston, Texas 77005, USA
| | - Y Zhang
- M.D. Anderson Cancer Center, Diagnostic Imaging Division, Houston, Texas 77005, USA
| | - A Dashko
- High Energy Density Science Center, University of Texas at Austin, Austin, Texas 78712, USA
| | - H Quevedo
- High Energy Density Science Center, University of Texas at Austin, Austin, Texas 78712, USA
| | - T Ditmire
- High Energy Density Science Center, University of Texas at Austin, Austin, Texas 78712, USA
| | - G Dyer
- SLAC National Accelerator Laboratory, Linac Coherent Light Source, Menlo Park, California 94025, USA
| |
Collapse
|
12
|
Wang B, Chen Z, Cen X, Liang Y, Tan L, Liang E, Zheng L, Zheng Y, Zhan Z, Cheng K. Highly Selective and Sensitive Chemiluminescent Probe for Leucine Aminopeptidase Detection in Vitro, in Vivo and in human Liver Cancer Tissue. Chem Sci 2022; 13:2324-2330. [PMID: 35310505 PMCID: PMC8864696 DOI: 10.1039/d1sc06528a] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2021] [Accepted: 01/17/2022] [Indexed: 12/24/2022] Open
Abstract
Leucine aminopeptidase (LAP) is involved in tumor cell proliferation, invasion, and angiogenesis, and is a well-known tumor marker. In recent years, chemiluminescence has been widely used in the field of biological imaging, due to it resulting in a high sensitivity and excellent signal-to-noise ratio. Here, we report the design, synthesis, and evaluation of the first LAP-activated chemiluminescent probe for LAP detection and imaging. The probe initially had no chemiluminescence but produced an extremely strong chemiluminescence after the release of the dioxetane intermediate in the presence of LAP. The probe had high selectivity over other proteases and higher signal-to-noise ratios than commercial fluorophores. Real-time imaging results indicated that the chemiluminescence was remarkably enhanced at the mice tumor site after the probe was injected. Furthermore, the chemiluminescence of this probe in the cancerous tissues of patients was obviously improved compared to that of normal tissues. Taken together, this study has developed the first LAP-activable chemiluminescent probe, which could be potentially used in protein detection, disease diagnosis, and drug development. The first chemiluminescent probe for the detection of LAP is described. It shows a highly selective, sensitive and rapid chemiluminescence response for the detection of LAP in vitro and in vivo, and enables the differentiation of liver cancer.![]()
Collapse
Affiliation(s)
- Baoqu Wang
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
| | - Zhenzhou Chen
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
| | - Xiaohong Cen
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
| | - Yuqing Liang
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
| | - Liyi Tan
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
| | - En Liang
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
| | - Lu Zheng
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
| | - Yanjun Zheng
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
| | - Zhikun Zhan
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
| | - Kui Cheng
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
- Department of Musculoskeletal Oncology, The Third Affiliated Hospital of Southern Medical University Guangzhou 510642 Guangdong Province People's Republic of China
| |
Collapse
|
13
|
Li X, Liang E, Hong X, Han X, Li C, Wang Y, Wang Z, Zheng A. In Vitro and In Vivo Bioequivalence Study of 3D-Printed Instant-Dissolving Levetiracetam Tablets and Subsequent Personalized Dosing for Chinese Children Based on Physiological Pharmacokinetic Modeling. Pharmaceutics 2021; 14:pharmaceutics14010020. [PMID: 35056916 PMCID: PMC8779920 DOI: 10.3390/pharmaceutics14010020] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2021] [Revised: 11/24/2021] [Accepted: 12/20/2021] [Indexed: 12/19/2022] Open
Abstract
Recently, the development of Binder Jet 3D printing technology has promoted the research and application of personalized formulations, which are especially useful for children’s medications. Additionally, physiological pharmacokinetic (PBPK) modeling can be used to guide drug development and drug dose selection. Multiple technologies can be used in combination to increase the safety and effectiveness of drug administration. In this study, we performed in vivo pharmacokinetic experiments in dogs with preprepared 3D-printed levetiracetam instant-dissolving tablets (LEV-IDTs). Bioequivalence analysis showed that the tablets were bioequivalent to commercially available preparations (Spritam®) for dogs. Additionally, we evaluated the bioequivalence of 3D-printed LEV-IDTs with Spritam® by a population-based simulation based on the established PBPK model of levetiracetam for Chinese adults. Finally, we established a PBPK model of oral levetiracetam in Chinese children by combining the physiological parameters of children, and we simulated the PK (pharmacokinetics) curves of Chinese children aged 4 and 6 years that were administered the drug to provide precise guidance on adjusting the dose according to the effective dose range of the drug. Briefly, utilizing both Binder jet 3D printing technology and PBPK models is a promising route for personalized drug delivery with various age groups.
Collapse
Affiliation(s)
- Xianfu Li
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, Haidian District, Beijing 100850, China; (X.L.); (E.L.); (X.H.); (X.H.); (C.L.)
| | - En Liang
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, Haidian District, Beijing 100850, China; (X.L.); (E.L.); (X.H.); (X.H.); (C.L.)
- Department Pharmaceut, School Pharm, Yantai University, 32th Qingquan Road, Laishan District, Yantai 264005, China
| | - Xiaoxuan Hong
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, Haidian District, Beijing 100850, China; (X.L.); (E.L.); (X.H.); (X.H.); (C.L.)
| | - Xiaolu Han
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, Haidian District, Beijing 100850, China; (X.L.); (E.L.); (X.H.); (X.H.); (C.L.)
| | - Conghui Li
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, Haidian District, Beijing 100850, China; (X.L.); (E.L.); (X.H.); (X.H.); (C.L.)
| | - Yuxi Wang
- Shanghai PharmoGo Co., Ltd., 3F, Block B, Weitai Building, No. 58, Lane 91, Eshan Road, Shanghai 200127, China;
| | - Zengming Wang
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, Haidian District, Beijing 100850, China; (X.L.); (E.L.); (X.H.); (X.H.); (C.L.)
- Correspondence: (Z.W.); (A.Z.); Tel.: +86-(0)10-668-74665 (Z.W.); +86-(0)10-669-31694 (A.Z.)
| | - Aiping Zheng
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, Haidian District, Beijing 100850, China; (X.L.); (E.L.); (X.H.); (X.H.); (C.L.)
- Correspondence: (Z.W.); (A.Z.); Tel.: +86-(0)10-668-74665 (Z.W.); +86-(0)10-669-31694 (A.Z.)
| |
Collapse
|
14
|
Huang Y, Liang E, Schaff E, Zhao B, Snyder K, Wen N, Chetty I, Shah M, Siddiqui S. Impact of MRI Sequence Resolution for Target Volume Definition in Stereotactic Radiosurgery. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.555] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
15
|
Zhang L, Zhao H, Ma Y, Cheng Y, Zhao Y, Cui J, Yang C, Zhang J, Wang P, Xu L, Yu J, Men L, Liang E, Yang D, Zhai Y. MA02.06 Phase 1b Study of Pelcitoclax (APG-1252) in Combination With Osimertinib in Patients With EGFR TKI-Resistant NSCLC. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.115] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
16
|
Zhao HC, Xia H, Hu S, Lv YY, Zhao ZR, He J, Liang E, Ni G, Chen LY, Qiu XP, Zhou SM, Zhao HB. Large ultrafast-modulated Voigt effect in noncollinear antiferromagnet Mn 3Sn. Nat Commun 2021; 12:5266. [PMID: 34489461 PMCID: PMC8421456 DOI: 10.1038/s41467-021-25654-9] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2021] [Accepted: 08/18/2021] [Indexed: 11/15/2022] Open
Abstract
The time-resolved magneto-optical (MO) Voigt effect can be utilized to study the Néel order dynamics in antiferromagnetic (AFM) materials, but it has been limited for collinear AFM spin configuration. Here, we have demonstrated that in Mn3Sn with an inverse triangular spin structure, the quench of AFM order by ultrafast laser pulses can result in a large Voigt effect modulation. The modulated Voigt angle is significantly larger than the polarization rotation due to the crystal-structure related linear dichroism effect and the modulated MO Kerr angle arising from the ferroic ordering of cluster magnetic octupole. The AFM order quench time shows negligible change with increasing temperature approaching the Néel temperature (TN), in markedly contrast with the pronounced slowing-down demagnetization typically observed in conventional magnetic materials. This atypical behavior can be explained by the influence of weakened Dzyaloshinskii–Moriya interaction rather than the smaller exchange splitting on the diminished AFM order near TN. The temperature-insensitive ultrafast spin manipulation can pave the way for high-speed spintronic devices either working at a wide range of temperature or demanding spin switching near TN. Mn3Sn is an anti-ferromagnetic material which displays a large magneto-optical Kerr effect, despite lacking a ferromagnetic moment. Here, the authors show that likewise, Mn3Sn, also presents a particularly large magneto-optical Voigt signal, with a negligible change in the quench time over a wide temperature range.
Collapse
Affiliation(s)
- H C Zhao
- Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education), and Shanghai Ultra-precision Optical Manufacturing Engineering Research Center, Department of Optical Science and Engineering, Fudan University, Shanghai, China
| | - H Xia
- Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education), and Shanghai Ultra-precision Optical Manufacturing Engineering Research Center, Department of Optical Science and Engineering, Fudan University, Shanghai, China.,Department of Physics, Fudan University, Shanghai, China
| | - S Hu
- Shanghai Key Laboratory of Special Artificial Microstructure Materials and Technology and Pohl Institute of Solid State Physics and School of Physics Science and Engineering, Tongji University, Shanghai, China
| | - Y Y Lv
- Shanghai Key Laboratory of Special Artificial Microstructure Materials and Technology and Pohl Institute of Solid State Physics and School of Physics Science and Engineering, Tongji University, Shanghai, China
| | - Z R Zhao
- Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education), and Shanghai Ultra-precision Optical Manufacturing Engineering Research Center, Department of Optical Science and Engineering, Fudan University, Shanghai, China
| | - J He
- Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education), and Shanghai Ultra-precision Optical Manufacturing Engineering Research Center, Department of Optical Science and Engineering, Fudan University, Shanghai, China
| | - E Liang
- Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education), and Shanghai Ultra-precision Optical Manufacturing Engineering Research Center, Department of Optical Science and Engineering, Fudan University, Shanghai, China
| | - G Ni
- Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education), and Shanghai Ultra-precision Optical Manufacturing Engineering Research Center, Department of Optical Science and Engineering, Fudan University, Shanghai, China.
| | - L Y Chen
- Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education), and Shanghai Ultra-precision Optical Manufacturing Engineering Research Center, Department of Optical Science and Engineering, Fudan University, Shanghai, China
| | - X P Qiu
- Shanghai Key Laboratory of Special Artificial Microstructure Materials and Technology and Pohl Institute of Solid State Physics and School of Physics Science and Engineering, Tongji University, Shanghai, China.
| | - S M Zhou
- Shanghai Key Laboratory of Special Artificial Microstructure Materials and Technology and Pohl Institute of Solid State Physics and School of Physics Science and Engineering, Tongji University, Shanghai, China.
| | - H B Zhao
- Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education), and Shanghai Ultra-precision Optical Manufacturing Engineering Research Center, Department of Optical Science and Engineering, Fudan University, Shanghai, China. .,Shanghai Frontier Base of Intelligent Optoelectronics and Perception, Institute of Optoelectronics, Fudan University, Shanghai, China.
| |
Collapse
|
17
|
Dai W, Zeng Y, Liang E, Zhou Q, Zhang L, Peng J. The actuality of resilience, social support and quality of life among patients with inflammatory bowel disease in China. Nurs Open 2021; 9:2190-2198. [PMID: 34037332 PMCID: PMC9190699 DOI: 10.1002/nop2.946] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2020] [Revised: 04/05/2021] [Accepted: 04/28/2021] [Indexed: 01/19/2023] Open
Abstract
Aim This study was conducted to increase knowledge on the actuality of resilience, social support and quality of life among inflammatory bowel disease patients in China to provide evidence for psychological support. Design Using convenience sampling, 249 outpatients and inpatients with inflammatory bowel disease from a hospital who completed the questionnaires were enrolled in the analytic questionnaire‐based study. Methods Demographic information forms, Resilience Scale for Inflammatory Bowel Disease, Social Support Rating Scale and Short Health Scale were administered. Results It was found that the resilience of patients with inflammatory bowel disease should be enhanced. When considering factors that influence resilience, the place of residence (living in rural areas) and utilization of social support should be considered. Resilience demonstrated a positive correlation with utilization of social support, and different place of residence was related to resilience. Targeted interventions should be implemented to increase patients’ resilience and quality of life.
Collapse
Affiliation(s)
- Weiwei Dai
- Xiangya Hospital Central South University, Changsha, China
| | - Yufeng Zeng
- Xiangya Hospital Central South University, Changsha, China
| | - E Liang
- Xiangya Hospital Central South University, Changsha, China
| | - Qiuhong Zhou
- Xiangya Hospital Central South University, Changsha, China
| | - Lei Zhang
- Xiangya Hospital Central South University, Changsha, China
| | - Jie Peng
- Xiangya Hospital Central South University, Changsha, China
| |
Collapse
|
18
|
Wells HL, Letko M, Lasso G, Ssebide B, Nziza J, Byarugaba DK, Navarrete-Macias I, Liang E, Cranfield M, Han BA, Tingley MW, Diuk-Wasser M, Goldstein T, Johnson CK, Mazet JAK, Chandran K, Munster VJ, Gilardi K, Anthony SJ. The evolutionary history of ACE2 usage within the coronavirus subgenus Sarbecovirus. Virus Evol 2021; 7:veab007. [PMID: 33754082 PMCID: PMC7928622 DOI: 10.1093/ve/veab007] [Citation(s) in RCA: 43] [Impact Index Per Article: 14.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
Severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) and SARS-CoV-2 are not phylogenetically closely related; however, both use the angiotensin-converting enzyme 2 (ACE2) receptor in humans for cell entry. This is not a universal sarbecovirus trait; for example, many known sarbecoviruses related to SARS-CoV-1 have two deletions in the receptor binding domain of the spike protein that render them incapable of using human ACE2. Here, we report three sequences of a novel sarbecovirus from Rwanda and Uganda that are phylogenetically intermediate to SARS-CoV-1 and SARS-CoV-2 and demonstrate via in vitro studies that they are also unable to utilize human ACE2. Furthermore, we show that the observed pattern of ACE2 usage among sarbecoviruses is best explained by recombination not of SARS-CoV-2, but of SARS-CoV-1 and its relatives. We show that the lineage that includes SARS-CoV-2 is most likely the ancestral ACE2-using lineage, and that recombination with at least one virus from this group conferred ACE2 usage to the lineage including SARS-CoV-1 at some time in the past. We argue that alternative scenarios such as convergent evolution are much less parsimonious; we show that biogeography and patterns of host tropism support the plausibility of a recombination scenario, and we propose a competitive release hypothesis to explain how this recombination event could have occurred and why it is evolutionarily advantageous. The findings provide important insights into the natural history of ACE2 usage for both SARS-CoV-1 and SARS-CoV-2 and a greater understanding of the evolutionary mechanisms that shape zoonotic potential of coronaviruses. This study also underscores the need for increased surveillance for sarbecoviruses in southwestern China, where most ACE2-using viruses have been found to date, as well as other regions such as Africa, where these viruses have only recently been discovered.
Collapse
Affiliation(s)
- H L Wells
- Department of Ecology, Evolution, and Environmental Biology, Columbia University, 1200 Amsterdam Ave, New York, NY 10027, USA
| | - M Letko
- Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 903 S. 4th St, Hamilton, MT 59840, USA.,Paul G. Allen School for Global Animal Health, Washington State University, 1155 College Ave, Pullman, WA 99164, USA
| | - G Lasso
- Department of Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10462, USA
| | - B Ssebide
- Gorilla Doctors, c/o MGVP, Inc., 1089 Veterinary Medicine Drive, Davis, CA 95616, USA
| | - J Nziza
- Gorilla Doctors, c/o MGVP, Inc., 1089 Veterinary Medicine Drive, Davis, CA 95616, USA
| | - D K Byarugaba
- Makerere University Walter Reed Project, Plot 42, Nakasero Road, Kampala, Uganda.,Makerere University, College of Veterinary Medicine, Living Stone Road, Kampala, Uganda
| | - I Navarrete-Macias
- Center for Infection and Immunity, Mailman School of Public Health, Columbia University, 722 W 168th St, New York, NY 10032, USA
| | - E Liang
- Center for Infection and Immunity, Mailman School of Public Health, Columbia University, 722 W 168th St, New York, NY 10032, USA
| | - M Cranfield
- One Health Institute and Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California Davis, 1089 Veterinary Medicine Drive, Davis, CA 95616, USA.,Department of Microbiology and Immunology, University of North Carolina School of Medicine, 125 Mason Farm Road, Chapel Hill, NC 27599, USA
| | - B A Han
- Cary Institute of Ecosystem Studies, 2801 Sharon Turnpike, Millbrook, NY 12545, USA
| | - M W Tingley
- Department of Ecology and Evolutionary Biology, University of California Los Angeles, 612 Charles E. Young Drive South, Los Angeles, CA 90095, USA
| | - M Diuk-Wasser
- Department of Ecology, Evolution, and Environmental Biology, Columbia University, 1200 Amsterdam Ave, New York, NY 10027, USA
| | - T Goldstein
- One Health Institute and Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California Davis, 1089 Veterinary Medicine Drive, Davis, CA 95616, USA
| | - C K Johnson
- One Health Institute and Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California Davis, 1089 Veterinary Medicine Drive, Davis, CA 95616, USA
| | - J A K Mazet
- One Health Institute and Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California Davis, 1089 Veterinary Medicine Drive, Davis, CA 95616, USA
| | - K Chandran
- Department of Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10462, USA
| | - V J Munster
- Paul G. Allen School for Global Animal Health, Washington State University, 1155 College Ave, Pullman, WA 99164, USA
| | - K Gilardi
- Makerere University Walter Reed Project, Plot 42, Nakasero Road, Kampala, Uganda.,One Health Institute and Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California Davis, 1089 Veterinary Medicine Drive, Davis, CA 95616, USA
| | - S J Anthony
- Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California Davis, One Shields Avenue, Davis, CA 95616, USA
| |
Collapse
|
19
|
Wells H, Letko M, Lasso G, Ssebide B, Nziza J, Byarugaba D, Navarrete-Macias I, Liang E, Cranfield M, Han B, Tingley M, Diuk-Wasser M, Goldstein T, Johnson C, Mazet J, Chandran K, Munster V, Gilardi K, Anthony S. The evolutionary history of ACE2 usage within the coronavirus subgenus Sarbecovirus. bioRxiv 2021:2020.07.07.190546. [PMID: 32676605 PMCID: PMC7359528 DOI: 10.1101/2020.07.07.190546] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
SARS-CoV-1 and SARS-CoV-2 are not phylogenetically closely related; however, both use the ACE2 receptor in humans for cell entry. This is not a universal sarbecovirus trait; for example, many known sarbecoviruses related to SARS-CoV-1 have two deletions in the receptor binding domain of the spike protein that render them incapable of using human ACE2. Here, we report three sequences of a novel sarbecovirus from Rwanda and Uganda which are phylogenetically intermediate to SARS-CoV-1 and SARS-CoV-2 and demonstrate via in vitro studies that they are also unable to utilize human ACE2. Furthermore, we show that the observed pattern of ACE2 usage among sarbecoviruses is best explained by recombination not of SARS-CoV-2, but of SARS-CoV-1 and its relatives. We show that the lineage that includes SARS-CoV-2 is most likely the ancestral ACE2-using lineage, and that recombination with at least one virus from this group conferred ACE2 usage to the lineage including SARS-CoV-1 at some time in the past. We argue that alternative scenarios such as convergent evolution are much less parsimonious; we show that biogeography and patterns of host tropism support the plausibility of a recombination scenario; and we propose a competitive release hypothesis to explain how this recombination event could have occurred and why it is evolutionarily advantageous. The findings provide important insights into the natural history of ACE2 usage for both SARS-CoV-1 and SARS-CoV-2, and a greater understanding of the evolutionary mechanisms that shape zoonotic potential of coronaviruses. This study also underscores the need for increased surveillance for sarbecoviruses in southwestern China, where most ACE2-using viruses have been found to date, as well as other regions such as Africa, where these viruses have only recently been discovered.
Collapse
Affiliation(s)
- H.L Wells
- Department of Ecology, Evolution, and Environmental Biology, Columbia University, New York, NY, USA
| | - M Letko
- Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA
- Paul G. Allen School for Global Animal Health, Washington State University, Pullman, WA, USA
| | - G Lasso
- Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY 10461, USA
| | - B Ssebide
- Gorilla Doctors, c/o MGVP, Inc., Davis, California, USA
| | - J Nziza
- Gorilla Doctors, c/o MGVP, Inc., Davis, California, USA
| | - D.K Byarugaba
- Makerere University Walter Reed Project, Kampala, Uganda
- Makerere University, College of Veterinary Medicine, Kampala, Uganda
| | - I Navarrete-Macias
- Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY, USA
| | - E Liang
- Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY, USA
| | - M Cranfield
- One Health Institute and Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California Davis, California, USA
- Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
| | - B.A Han
- Cary Institute of Ecosystem Studies, Millbrook, New York, USA
| | - M.W Tingley
- Department of Ecology and Evolutionary Biology, University of California Los Angeles, Los Angeles, CA, USA
| | - M Diuk-Wasser
- Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA
| | - T Goldstein
- One Health Institute and Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California Davis, California, USA
| | - C.K Johnson
- One Health Institute and Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California Davis, California, USA
| | - J Mazet
- One Health Institute and Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California Davis, California, USA
| | - K Chandran
- Gorilla Doctors, c/o MGVP, Inc., Davis, California, USA
| | - V.J Munster
- Paul G. Allen School for Global Animal Health, Washington State University, Pullman, WA, USA
| | - K Gilardi
- Makerere University Walter Reed Project, Kampala, Uganda
- One Health Institute and Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California Davis, California, USA
| | - S.J Anthony
- Department of Ecology, Evolution, and Environmental Biology, Columbia University, New York, NY, USA
- Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California Davis, California, USA
| |
Collapse
|
20
|
Chen J, Liang E, Shi J, Wu Y, Wen K, Yao X, Tang X. Metal-free synthesis of 1,4-benzodiazepines and quinazolinones from hexafluoroisopropyl 2-aminobenzoates at room temperature. RSC Adv 2021; 11:4966-4970. [PMID: 35424458 PMCID: PMC8694548 DOI: 10.1039/d1ra00324k] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2021] [Accepted: 01/20/2021] [Indexed: 11/29/2022] Open
Abstract
Herein, we describe the novel reactivity of hexafluoroisopropyl 2-aminobenzoates. The metal-free synthesis of 1,4-benzodiazepines and quinazolinones from hexafluoroisopropyl 2-aminobenzoates has been developed at room temperature. These procedures feature good functional group tolerance, mild reaction conditions, and excellent yields. The newly formed products can readily be converted to other useful N-heterocycles. Moreover, the products and their derivatives showed potent anticancer activities in vitro by MTT assay. A metal-free synthesis of 1,4-benzodiazepines and quinazolinones from hexafluoroisopropyl 2-aminobenzoates has been developed at room temperature.![]()
Collapse
Affiliation(s)
- Jiewen Chen
- Guangdong Provincial Key Laboratory of New Drug Screening
- School of Pharmaceutical Sciences
- Southern Medical University
- Guangzhou 510515
- P. R. China
| | - En Liang
- Guangdong Provincial Key Laboratory of New Drug Screening
- School of Pharmaceutical Sciences
- Southern Medical University
- Guangzhou 510515
- P. R. China
| | - Jie Shi
- Guangdong Provincial Key Laboratory of New Drug Screening
- School of Pharmaceutical Sciences
- Southern Medical University
- Guangzhou 510515
- P. R. China
| | - Yinrong Wu
- Guangdong Provincial Key Laboratory of New Drug Screening
- School of Pharmaceutical Sciences
- Southern Medical University
- Guangzhou 510515
- P. R. China
| | - Kangmei Wen
- Guangdong Provincial Key Laboratory of New Drug Screening
- School of Pharmaceutical Sciences
- Southern Medical University
- Guangzhou 510515
- P. R. China
| | - Xingang Yao
- Guangdong Provincial Key Laboratory of New Drug Screening
- School of Pharmaceutical Sciences
- Southern Medical University
- Guangzhou 510515
- P. R. China
| | - Xiaodong Tang
- Guangdong Provincial Key Laboratory of New Drug Screening
- School of Pharmaceutical Sciences
- Southern Medical University
- Guangzhou 510515
- P. R. China
| |
Collapse
|
21
|
Liang E, Li X, Fu W, Zhao C, Yang B, Yang Z. COP9 Signalosome Subunit 3 Restricts Neuroinflammatory Responses During Cerebral Ischemia/Reperfusion Injury Through Stabilizing Suppressor of Cytokine Signaling 3 Protein. Neuropsychiatr Dis Treat 2021; 17:1217-1227. [PMID: 33911869 PMCID: PMC8075360 DOI: 10.2147/ndt.s298966] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/30/2020] [Accepted: 03/22/2021] [Indexed: 11/23/2022] Open
Abstract
BACKGROUND The suppressor of cytokine signaling 3 (SOCS3) is a specific negative regulator of signal transducer and activator of transcription 3 (STAT3) signaling, which is predominantly activated to induce neuroinflammatory response in microglia and functions essential roles during cerebral ischemia-reperfusion (I/R) injury. Constitutive photomorphogenesis 9 (COP9) signalosome (CSN) is a signaling platform controlling protein stability by remodeling of cullin-RING ubiquitin ligases, which is recently reported to specifically recognize proteins with SOCS-box domains. However, whether SOCS3 is related to COP9 signalosome in neuroinflammation during cerebral I/R injury is completely unclear. METHODS Mice subjected to transient middle cerebral artery occlusion (MCAO) and reperfusion, and BV2 microglia cells treated with oxygen-glucose deprivation and reoxygenation (OGD/R) were used to mimic cerebral I/R injury. Western blot, qRTPCR, immunofluorescence, and co-Immunoprecipitation assays were performed to explore the regulatory mechanism of SOCS3 on neuroinflammation and the relationship of SOCS3 and COP9 signalosome during cerebral I/R injury. RESULTS SOCS3 expression is significantly upregulated in microglia during OGD/R treatment, and overexpression of SOCS3 suppresses OGD/R-induced STAT3 activation and inflammatory factor expression. Furthermore, we find that COP9 signalosome subunit 3 (CSN3) interacts with SOCS3 protein to enhance its stability, thereby resulting in restricting OGD/R-induced STAT3 activation and inflammatory response. Moreover, we find that knockdown of CSN3 evidently accelerates STAT3 activation, and aggravates cerebral I/R injury in vivo. CONCLUSION CSN3 restricts neuroinflammatory responses during cerebral I/R injury through stabilizing SOCS3 protein and indicates that CSN3 a potential therapeutic target for cerebral I/R injury.
Collapse
Affiliation(s)
- En Liang
- Department of Neurosurgery, The Affiliated Hexian Memorial Hospital of Southern Medical University, Guangzhou, People's Republic of China
| | - Xiaojun Li
- Centre for Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China
| | - Wenjun Fu
- Centre for Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China
| | - Changtong Zhao
- Department of Neurosurgery, The Affiliated Hexian Memorial Hospital of Southern Medical University, Guangzhou, People's Republic of China
| | - Baoying Yang
- Department of Neurosurgery, Guangdong Sanjiu Brain Hospital, Guangzhou, People's Republic of China
| | - Zhonghua Yang
- Centre for Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China
| |
Collapse
|
22
|
Liang E, Morris E, Vono J, Bazan L, Lu M, Modh A, Glide-Hurst C. Coupling Continuous Positive Airway Pressure (CPAP) and MR-guided Radiation Therapy. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.942] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
23
|
Wu Y, Lu X, Wang H, Liang E, Yuan Y, Zhao Q, Zhu Z, Huang J, Tang X. Acid-Catalyzed Synthesis of Quinoline Derivatives from 2-Methylquinolines and 2-Aryloxy/Alkoxybenzaldehyde in Aqueous Medium. European J Org Chem 2019. [DOI: 10.1002/ejoc.201901331] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- Yinrong Wu
- Guangdong Provincial Key Laboratory of New Drug Screening; School of Pharmaceutical Sciences; Southern Medical University; 1023 South Shatai Road, Baiyun District 510515 Guangzhou P. R. China
| | - Xianchen Lu
- Guangdong Provincial Key Laboratory of New Drug Screening; School of Pharmaceutical Sciences; Southern Medical University; 1023 South Shatai Road, Baiyun District 510515 Guangzhou P. R. China
| | - Hang Wang
- Guangdong Provincial Key Laboratory of New Drug Screening; School of Pharmaceutical Sciences; Southern Medical University; 1023 South Shatai Road, Baiyun District 510515 Guangzhou P. R. China
| | - En Liang
- Guangdong Provincial Key Laboratory of New Drug Screening; School of Pharmaceutical Sciences; Southern Medical University; 1023 South Shatai Road, Baiyun District 510515 Guangzhou P. R. China
| | - Yingying Yuan
- Guangdong Provincial Key Laboratory of New Drug Screening; School of Pharmaceutical Sciences; Southern Medical University; 1023 South Shatai Road, Baiyun District 510515 Guangzhou P. R. China
| | - Qiaorun Zhao
- Guangdong Provincial Key Laboratory of New Drug Screening; School of Pharmaceutical Sciences; Southern Medical University; 1023 South Shatai Road, Baiyun District 510515 Guangzhou P. R. China
| | - Zhongzhi Zhu
- School of Biotechnology and Health Sciences; Wuyi University; 529020 Jiangmen China
| | - Jiaping Huang
- Guangdong Provincial Key Laboratory of New Drug Screening; School of Pharmaceutical Sciences; Southern Medical University; 1023 South Shatai Road, Baiyun District 510515 Guangzhou P. R. China
| | - Xiaodong Tang
- Guangdong Provincial Key Laboratory of New Drug Screening; School of Pharmaceutical Sciences; Southern Medical University; 1023 South Shatai Road, Baiyun District 510515 Guangzhou P. R. China
| |
Collapse
|
24
|
Liang E, Wang J, Wu Y, Huang L, Yao X, Tang X. Direct Alkenylation of 2‐Methylquinolines with Aldehydes through Synergistic Catalysis of 1,3‐Dimethylbarbituric Acid and HOAc. Adv Synth Catal 2019. [DOI: 10.1002/adsc.201900351] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
- En Liang
- Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical SciencesSouthern Medical University 1023 South Shatai Road, Baiyun District Guangzhou 510515 People's Republic of China
| | - Junqi Wang
- Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical SciencesSouthern Medical University 1023 South Shatai Road, Baiyun District Guangzhou 510515 People's Republic of China
| | - Yinrong Wu
- Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical SciencesSouthern Medical University 1023 South Shatai Road, Baiyun District Guangzhou 510515 People's Republic of China
| | - Liangbin Huang
- Key Laboratory of Functional Molecular Engineering of Guangdong Province, School of Chemistry and Chemical EngineeringSouth China University of Technology 381 Wushan Road Guangzhou 510640 People's Republic of China
| | - Xingang Yao
- Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical SciencesSouthern Medical University 1023 South Shatai Road, Baiyun District Guangzhou 510515 People's Republic of China
| | - Xiaodong Tang
- Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical SciencesSouthern Medical University 1023 South Shatai Road, Baiyun District Guangzhou 510515 People's Republic of China
| |
Collapse
|
25
|
Goldstein T, Anthony S, Gbakima A, Bird B, Bangura J, Tremeau-Bravard A, Belaganahalli M, Wells H, Dhanota J, Liang E, Grodus M, Jangra R, Dejesus V, Lasso G, Smith B, Jambai A, Kamara B, Kamara S, Bangura W, Monagin C, Shapira S, Johnson CK, Saylors K, Rubin E, Chandran K, Lipkin W, Mazet J. The discovery of a new Ebolavirus, Bombali virus, adds further support for bats as hosts of Ebolaviruses. Int J Infect Dis 2019. [DOI: 10.1016/j.ijid.2018.11.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
26
|
Br A, Dovih P, Ramakrishnan U, Liang E, Mendenhall I, Hong DW, Smith G. Evidence of filovirus and henipavirus in bats and bat harvesters, India. Int J Infect Dis 2019. [DOI: 10.1016/j.ijid.2018.11.156] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
27
|
|
28
|
Schaenman J, Rossetti M, Sidwell T, Groysberg V, Sunga G, Liang E, Vangala S, Chang E, Bakir M, Bondar G, Cadeiras M, Kwon M, Reed E, Deng M. Frequency of Monocyte Subtypes and TLR4 Expression Correlate with Clinical Outcomes After Mechanical Circulatory Device Implantation. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
29
|
Abstract
Objective 1) To study the current use of abdominal X-rays (AXR) in our emergency department (ED). 2) To evaluate the clinical predictors for positive AXR findings. Methods During the 40 days study period, all patients who had taken abdominal X-rays were included. The attending doctor filled in a questionnaire on demographic data, clinical features and outcome. The three radiologists who participated in this study reported the films and consultant emergency physicians then commented on the appropriateness of the request. The clinical features, which were predictive of positive radiological findings, were sorted out using univariate analysis. Results 64 patients were included in the 40 days study period. The rate for AXR request was 3.4 per 1000 patients. The most common presenting complaints were abdominal pain (85.9%) and constipation (45.3%). The most frequent clinical findings were abdominal distension (35.9%) and hyperactive bowel sound (31.3%). Only two of the clinical features, including vomiting and rebound tenderness, were found to have significant correlation with positive X-ray findings. Most of the AXR requests and interpretations by ED doctors were considered to be appropriate.
Collapse
Affiliation(s)
| | - Tw Wong
- Pamela Youde Nethersole Eastern Hospital, Accident & Emergency Department, 3 Lok Man Road, Chaiwan, Hong Kong
| | | | - E Liang
- Pamela Youde Nethersole Eastern Hospital, Department of Radiology, 3 Lok Man Road, Chaiwan, Hong Kong
| | - Yk Fu
- Pamela Youde Nethersole Eastern Hospital, Department of Radiology, 3 Lok Man Road, Chaiwan, Hong Kong
| | - J Khoo
- Pamela Youde Nethersole Eastern Hospital, Department of Radiology, 3 Lok Man Road, Chaiwan, Hong Kong
| |
Collapse
|
30
|
Gao J, Liang E, Ma R, Li F, Liu Y, Liu J, Jiang L, Li C, Dai H, Wu J, Su X, He W, Ruan K. Fluorine Pseudocontact Shifts Used for Characterizing the Protein-Ligand Interaction Mode in the Limit of NMR Intermediate Exchange. Angew Chem Int Ed Engl 2017. [DOI: 10.1002/ange.201707114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Jia Gao
- Hefei National Laboratory for Physical Science at the Microscale; School of Life Science; University of Science and Technology of China; Huangshan Road Hefei Anhui 230027 P. R. China
- Center of Medical Physics and Technology; Hefei Institute of Physical Science, Cancer Hospital; Chinese Academy of Science; Hefei Anhui 230031 P. R. China
| | - E Liang
- Department of pharmacology and Pharmaceutical Sciences; School of Medicine, Tsinghua-Peking Joint centers for Lifer Sciences; Tsinghua University; Beijing 100084 P. R. China
| | - Rongsheng Ma
- Hefei National Laboratory for Physical Science at the Microscale; School of Life Science; University of Science and Technology of China; Huangshan Road Hefei Anhui 230027 P. R. China
| | - Fudong Li
- Hefei National Laboratory for Physical Science at the Microscale; School of Life Science; University of Science and Technology of China; Huangshan Road Hefei Anhui 230027 P. R. China
| | - Yixiang Liu
- Key Laboratory of Magnet Resonance in Biological Systems; State Key Laboratory of Magnet Resonance and Atomic and Molecular Physics; Wuhan Center for Magnet Resonance Department; Wuhan Institute of Physics and Mathematics; Chinese Academy of Science; Wuhan Hubei 430071 P. R. China
| | - Jiuyang Liu
- Hefei National Laboratory for Physical Science at the Microscale; School of Life Science; University of Science and Technology of China; Huangshan Road Hefei Anhui 230027 P. R. China
| | - Ling Jiang
- Key Laboratory of Magnet Resonance in Biological Systems; State Key Laboratory of Magnet Resonance and Atomic and Molecular Physics; Wuhan Center for Magnet Resonance Department; Wuhan Institute of Physics and Mathematics; Chinese Academy of Science; Wuhan Hubei 430071 P. R. China
| | - Conggang Li
- Key Laboratory of Magnet Resonance in Biological Systems; State Key Laboratory of Magnet Resonance and Atomic and Molecular Physics; Wuhan Center for Magnet Resonance Department; Wuhan Institute of Physics and Mathematics; Chinese Academy of Science; Wuhan Hubei 430071 P. R. China
| | - Haiming Dai
- Center of Medical Physics and Technology; Hefei Institute of Physical Science, Cancer Hospital; Chinese Academy of Science; Hefei Anhui 230031 P. R. China
| | - Jihui Wu
- Hefei National Laboratory for Physical Science at the Microscale; School of Life Science; University of Science and Technology of China; Huangshan Road Hefei Anhui 230027 P. R. China
| | - Xuncheng Su
- State Key Laboratory of Elemento-Organic Chemistry; Collatorative Innovation Center of Chemical Science and Engineering(Tianjin); Nankai University; Tianjin 300071 P. R. China
| | - Wei He
- Department of pharmacology and Pharmaceutical Sciences; School of Medicine, Tsinghua-Peking Joint centers for Lifer Sciences; Tsinghua University; Beijing 100084 P. R. China
| | - Ke Ruan
- Hefei National Laboratory for Physical Science at the Microscale; School of Life Science; University of Science and Technology of China; Huangshan Road Hefei Anhui 230027 P. R. China
| |
Collapse
|
31
|
Gao J, Liang E, Ma R, Li F, Liu Y, Liu J, Jiang L, Li C, Dai H, Wu J, Su X, He W, Ruan K. Fluorine Pseudocontact Shifts Used for Characterizing the Protein-Ligand Interaction Mode in the Limit of NMR Intermediate Exchange. Angew Chem Int Ed Engl 2017; 56:12982-12986. [DOI: 10.1002/anie.201707114] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2017] [Revised: 08/15/2017] [Indexed: 11/10/2022]
Affiliation(s)
- Jia Gao
- Hefei National Laboratory for Physical Science at the Microscale; School of Life Science; University of Science and Technology of China; Huangshan Road Hefei Anhui 230027 P. R. China
- Center of Medical Physics and Technology; Hefei Institute of Physical Science, Cancer Hospital; Chinese Academy of Science; Hefei Anhui 230031 P. R. China
| | - E Liang
- Department of pharmacology and Pharmaceutical Sciences; School of Medicine, Tsinghua-Peking Joint centers for Lifer Sciences; Tsinghua University; Beijing 100084 P. R. China
| | - Rongsheng Ma
- Hefei National Laboratory for Physical Science at the Microscale; School of Life Science; University of Science and Technology of China; Huangshan Road Hefei Anhui 230027 P. R. China
| | - Fudong Li
- Hefei National Laboratory for Physical Science at the Microscale; School of Life Science; University of Science and Technology of China; Huangshan Road Hefei Anhui 230027 P. R. China
| | - Yixiang Liu
- Key Laboratory of Magnet Resonance in Biological Systems; State Key Laboratory of Magnet Resonance and Atomic and Molecular Physics; Wuhan Center for Magnet Resonance Department; Wuhan Institute of Physics and Mathematics; Chinese Academy of Science; Wuhan Hubei 430071 P. R. China
| | - Jiuyang Liu
- Hefei National Laboratory for Physical Science at the Microscale; School of Life Science; University of Science and Technology of China; Huangshan Road Hefei Anhui 230027 P. R. China
| | - Ling Jiang
- Key Laboratory of Magnet Resonance in Biological Systems; State Key Laboratory of Magnet Resonance and Atomic and Molecular Physics; Wuhan Center for Magnet Resonance Department; Wuhan Institute of Physics and Mathematics; Chinese Academy of Science; Wuhan Hubei 430071 P. R. China
| | - Conggang Li
- Key Laboratory of Magnet Resonance in Biological Systems; State Key Laboratory of Magnet Resonance and Atomic and Molecular Physics; Wuhan Center for Magnet Resonance Department; Wuhan Institute of Physics and Mathematics; Chinese Academy of Science; Wuhan Hubei 430071 P. R. China
| | - Haiming Dai
- Center of Medical Physics and Technology; Hefei Institute of Physical Science, Cancer Hospital; Chinese Academy of Science; Hefei Anhui 230031 P. R. China
| | - Jihui Wu
- Hefei National Laboratory for Physical Science at the Microscale; School of Life Science; University of Science and Technology of China; Huangshan Road Hefei Anhui 230027 P. R. China
| | - Xuncheng Su
- State Key Laboratory of Elemento-Organic Chemistry; Collatorative Innovation Center of Chemical Science and Engineering(Tianjin); Nankai University; Tianjin 300071 P. R. China
| | - Wei He
- Department of pharmacology and Pharmaceutical Sciences; School of Medicine, Tsinghua-Peking Joint centers for Lifer Sciences; Tsinghua University; Beijing 100084 P. R. China
| | - Ke Ruan
- Hefei National Laboratory for Physical Science at the Microscale; School of Life Science; University of Science and Technology of China; Huangshan Road Hefei Anhui 230027 P. R. China
| |
Collapse
|
32
|
Reich K, Blauvelt A, Armstrong A, Langley RG, Fox T, Huang J, Papavassilis C, Liang E, Lloyd P, Bruin G. Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits minimal immunogenicity in patients with moderate-to-severe plaque psoriasis. Br J Dermatol 2016; 176:752-758. [PMID: 27518376 DOI: 10.1111/bjd.14965] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/05/2016] [Indexed: 12/20/2022]
Abstract
BACKGROUND The proinflammatory cytokine interleukin (IL)-17A plays a pivotal role in psoriasis pathogenesis. Secukinumab, a fully human monoclonal antibody (mAb) that selectively targets IL-17A, has been demonstrated to be highly efficacious for the treatment of moderate-to-severe psoriasis, starting at early time points, with a sustained effect and a favourable safety profile. mAb therapies may be associated with production of antidrug antibodies (ADAs) that can affect drug pharmacokinetics, diminish response or cause hypersensitivity reactions. OBJECTIVES To investigate the immunogenicity of secukinumab across six phase III clinical trials in which patients with plaque psoriasis were treated with secukinumab for up to 52 weeks and additionally followed up at week 60. METHODS Immunogenicity in patients with plaque psoriasis exposed to secukinumab was evaluated at baseline and at weeks 12, 24, 52 and 60. Treatment-emergent (TE)-ADAs were defined as a positive ADA signal detected in post-treatment samples from patients with a negative baseline signal. Confirmed positive samples were further analysed for their drug-neutralizing potential. RESULTS Among 2842 patients receiving secukinumab and evaluated for ADAs, 11 (0·4%) developed TE-ADAs. Associations between TE-ADAs and secukinumab dose, frequency or mode of administration were not observed. Neutralizing antibodies were detected in three of nine evaluable patients with TE-ADAs. CONCLUSIONS Secukinumab immunogenicity was low, as shown by TE-ADA detection in only 11 of 2842 (0·4%) patients with moderate-to-severe plaque psoriasis treated with secukinumab. All but one of the patients with TE-ADAs were biologic naive. Neither TE-ADAs nor neutralizing antibodies were associated with loss of secukinumab efficacy or issues of clinical concern.
Collapse
Affiliation(s)
- K Reich
- Dermatologikum Hamburg and SCIderm Research Institute, Hamburg, Germany
| | - A Blauvelt
- Oregon Medical Research Center, Portland, OR, U.S.A
| | - A Armstrong
- University of Southern California, Los Angeles, CA, U.S.A
| | | | - T Fox
- Novartis Pharma AG, Basel, Switzerland
| | - J Huang
- Novartis Pharmaceuticals Corporation, East Hanover, NJ, U.S.A
| | | | - E Liang
- Novartis Institutes for Biomedical Research, Basel, Switzerland
| | - P Lloyd
- Novartis Institutes for Biomedical Research, Basel, Switzerland
| | - G Bruin
- Novartis Institutes for Biomedical Research, Basel, Switzerland
| |
Collapse
|
33
|
Liu B, Wang Y, Zhu H, Liang E, Camarero JJ. Topography and age mediate the growth responses of Smith fir to climate warming in the southeastern Tibetan Plateau. Int J Biometeorol 2016; 60:1577-1587. [PMID: 26939794 DOI: 10.1007/s00484-016-1148-5] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/20/2015] [Revised: 02/18/2016] [Accepted: 02/18/2016] [Indexed: 06/05/2023]
Abstract
The Tibetan Plateau holds some of the world's highest undisturbed natural treelines and timberlines. Such extreme environments constitute potentially valuable monitoring sites of the effects of climate warming on high-elevation forests. Here, we analyze a network of 21 Smith fir forests situated in the Sygera Mountains, southeastern Tibetan Plateau, using tree-ring width (TRW) and basal area increment (BAI) chronologies. Sampled sites encompassed a wide elevation gradient, from 3600 to 4400 m, including some treeline sites and diverse aspects and tree ages. In comparison with TRW series, BAI series better capture the long-term warming signal. Previous November and current April and summer temperatures are the dominant climatic factors controlling Smith fir radial growth. The mean inter-series correlations of TRW increased upwards, but the forest limit presented the highest potential to reconstruct past temperature variability. Moreover, the growth responses of young trees were less stable than those of trees older than 100 years. Climate warming is accelerating radial growth of Smith fir forest subjected to mesic conditions. Collectively, these findings confirm that the effects of site elevation and tree age should be considered when quantifying climate-growth relationships. The type of tree-ring data (BAI vs. TRW) is also relevant since BAI indices seem to be a better climatic proxy of low-frequency temperature signals than TRW indices. Therefore, site (e.g., elevation) and tree (e.g., age) features should be considered to properly evaluate the effects of climate warming on growth of high-elevation forests.
Collapse
Affiliation(s)
- B Liu
- Key Laboratory of Alpine Ecology and Biodiversity, Key Laboratory of Tibetan Environment Changes and Land Surface Processes, Institute of Tibetan Plateau Research, Chinese Academy of Sciences, Beijing, 100101, China
- College of Urban and Environmental Sciences, Northwest University, Xi'an, 710127, China
| | - Y Wang
- Key Laboratory of Alpine Ecology and Biodiversity, Key Laboratory of Tibetan Environment Changes and Land Surface Processes, Institute of Tibetan Plateau Research, Chinese Academy of Sciences, Beijing, 100101, China
| | - H Zhu
- Key Laboratory of Alpine Ecology and Biodiversity, Key Laboratory of Tibetan Environment Changes and Land Surface Processes, Institute of Tibetan Plateau Research, Chinese Academy of Sciences, Beijing, 100101, China
- CAS Center for Excellence in Tibetan Plateau Earth Sciences, Beijing, 100101, China
| | - E Liang
- Key Laboratory of Alpine Ecology and Biodiversity, Key Laboratory of Tibetan Environment Changes and Land Surface Processes, Institute of Tibetan Plateau Research, Chinese Academy of Sciences, Beijing, 100101, China.
- CAS Center for Excellence in Tibetan Plateau Earth Sciences, Beijing, 100101, China.
| | - J J Camarero
- Instituto Pirenaico de Ecología (IPE-CSIC), Avda. Montañana, 1005, 50059, Zaragoza, Spain
| |
Collapse
|
34
|
Liang E, Brown B, Rachinsky M. Clinical efficacy of uterine artery embolization using PVA form particles to treat symptomatic adenomyosis. J Vasc Interv Radiol 2016. [DOI: 10.1016/j.jvir.2015.12.522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
35
|
Rice S, Liang E, Geye H, Kimple R. Skin Cancers of the Head and Neck: A 21-Year Single-Institution Experience. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.1699] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
36
|
Klein U, Liang E, Vogel B, Kolbinger F, Bruin G, Lloyd P. SAT0142 Immunogenicity of the Novel Anti-Il-17A Antibody, Secukinumab, with Intravenous and Subcutaneous Dosing Regimens in Healthy Subjects and Patients. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.1868] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
37
|
Anthony SJ, Ojeda-Flores R, Rico-Chávez O, Navarrete-Macias I, Zambrana-Torrelio CM, Rostal MK, Epstein JH, Tipps T, Liang E, Sanchez-Leon M, Sotomayor-Bonilla J, Aguirre AA, Ávila-Flores R, Medellín RA, Goldstein T, Suzán G, Daszak P, Lipkin WI. Coronaviruses in bats from Mexico. J Gen Virol 2013; 94:1028-1038. [PMID: 23364191 PMCID: PMC3709589 DOI: 10.1099/vir.0.049759-0] [Citation(s) in RCA: 127] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
Bats are reservoirs for a wide range of human pathogens including Nipah, Hendra, rabies, Ebola, Marburg and severe acute respiratory syndrome coronavirus (CoV). The recent implication of a novel beta (β)-CoV as the cause of fatal respiratory disease in the Middle East emphasizes the importance of surveillance for CoVs that have potential to move from bats into the human population. In a screen of 606 bats from 42 different species in Campeche, Chiapas and Mexico City we identified 13 distinct CoVs. Nine were alpha (α)-CoVs; four were β-CoVs. Twelve were novel. Analyses of these viruses in the context of their hosts and ecological habitat indicated that host species is a strong selective driver in CoV evolution, even in allopatric populations separated by significant geographical distance; and that a single species/genus of bat can contain multiple CoVs. A β-CoV with 96.5 % amino acid identity to the β-CoV associated with human disease in the Middle East was found in a Nyctinomops laticaudatus bat, suggesting that efforts to identify the viral reservoir should include surveillance of the bat families Molossidae/Vespertilionidae, or the closely related Nycteridae/Emballonuridae. While it is important to investigate unknown viral diversity in bats, it is also important to remember that the majority of viruses they carry will not pose any clinical risk, and bats should not be stigmatized ubiquitously as significant threats to public health.
Collapse
Affiliation(s)
- S J Anthony
- EcoHealth Alliance, 460 West 34th Street, NY, USA
- Center for Infection and Immunity, Mailman School of Public Health, Columbia University, 722 West 168th Street, NY, USA
| | - R Ojeda-Flores
- Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, Ciudad Universitaria, 04510, México D.F. Mexico
| | - O Rico-Chávez
- Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, Ciudad Universitaria, 04510, México D.F. Mexico
| | - I Navarrete-Macias
- Center for Infection and Immunity, Mailman School of Public Health, Columbia University, 722 West 168th Street, NY, USA
| | | | - M K Rostal
- EcoHealth Alliance, 460 West 34th Street, NY, USA
| | - J H Epstein
- EcoHealth Alliance, 460 West 34th Street, NY, USA
| | - T Tipps
- EcoHealth Alliance, 460 West 34th Street, NY, USA
| | - E Liang
- EcoHealth Alliance, 460 West 34th Street, NY, USA
- Center for Infection and Immunity, Mailman School of Public Health, Columbia University, 722 West 168th Street, NY, USA
| | - M Sanchez-Leon
- EcoHealth Alliance, 460 West 34th Street, NY, USA
- Center for Infection and Immunity, Mailman School of Public Health, Columbia University, 722 West 168th Street, NY, USA
| | - J Sotomayor-Bonilla
- Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, Ciudad Universitaria, 04510, México D.F. Mexico
| | - A A Aguirre
- George Mason University, 1500 Remount Road, Front Royal, Virginia, USA
| | - R Ávila-Flores
- Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, Ciudad Universitaria, 04510, México D.F. Mexico
| | - R A Medellín
- Instituto de Ecología, Universidad Nacional Autónoma de México, Ap. Postal 70-275, 04510, México, D.F. Mexico
| | - T Goldstein
- One Health Institute, School of Veterinary Medicine, One Shields Ave, University of California Davis, California USA
| | - G Suzán
- Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, Ciudad Universitaria, 04510, México D.F. Mexico
| | - P Daszak
- EcoHealth Alliance, 460 West 34th Street, NY, USA
| | - W I Lipkin
- Center for Infection and Immunity, Mailman School of Public Health, Columbia University, 722 West 168th Street, NY, USA
| |
Collapse
|
38
|
Hogstrom K, McLaughlin D, Gibbons J, Shikhaliev P, Clarke T, Henderson A, Taylor D, Shagin P, Liang E. SU-D-BRCD-06: Measurement of Elekta Electron Energy Spectra Using a Small Magnetic Spectrometer. Med Phys 2012; 39:3614. [PMID: 28517408 DOI: 10.1118/1.4734672] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
PURPOSE To demonstrate how a small magnetic spectrometer can measure the energy spectra of seven electron beams on an Elekta Infinity tuned to match beams on a previously commissioned machine. METHODS Energyspectra were determined from measurements of intensity profiles on 6″-long computed radiographic (CR) strips after deflecting a narrow incident beam using a small (28 lbs.), permanent magnetic spectrometer. CR plateexposures (<1cGy) required special beam reduction techniques and bremsstrahlung shielding. Curves of CR intensity (corrected for non- linearity and background) versus position were transformed into energy spectra using the transformation from position (x) on the CR plate to energy (E) based on the Lorentz force law. The effective magnetic field and its effective edge, parameters in the transformation, were obtained by fitting a plot of most probable incident energy (determined from practical range) to the peak position. RESULTS The calibration curve (E vs. x) fit gave 0.423 Tesla for the effective magnetic field. Most resulting energy spectra were characterized by a single, asymmetric peak with peak position and FWHM increasing monotonically with beam energy. Only the 9-MeV spectrum was atypical, possibly indicating suboptimal beam tuning. These results compared well with energy spectra independently determined by adjusting each spectrum until the EGSnrc Monte Carlo calculated percent depth-dose curve agreed well with the corresponding measured curve. CONCLUSIONS Results indicate that this spectrometer and methodology could be useful for measuring energy spectra of clinical electron beams at isocenter. Future work will (1) remove the small effect of the detector response function (due to pinhole size and incident angular spread) from the energy spectra, (2) extract the energy spectra exiting the accelerator from current results, (3) use the spectrometer to compare energy spectra of matched beams among our clinical sites, and (4) modify the spectrometer to utilize radiochromic film.
Collapse
Affiliation(s)
- K Hogstrom
- Mary Bird Perkins Cancer Center, Baton Rouge, LA.,Louisiana State University and A & M College, Baton Rouge, LA.,Rice University, Houston, TX
| | - D McLaughlin
- Mary Bird Perkins Cancer Center, Baton Rouge, LA.,Louisiana State University and A & M College, Baton Rouge, LA.,Rice University, Houston, TX
| | - J Gibbons
- Mary Bird Perkins Cancer Center, Baton Rouge, LA.,Louisiana State University and A & M College, Baton Rouge, LA.,Rice University, Houston, TX
| | - P Shikhaliev
- Mary Bird Perkins Cancer Center, Baton Rouge, LA.,Louisiana State University and A & M College, Baton Rouge, LA.,Rice University, Houston, TX
| | - T Clarke
- Mary Bird Perkins Cancer Center, Baton Rouge, LA.,Louisiana State University and A & M College, Baton Rouge, LA.,Rice University, Houston, TX
| | - A Henderson
- Mary Bird Perkins Cancer Center, Baton Rouge, LA.,Louisiana State University and A & M College, Baton Rouge, LA.,Rice University, Houston, TX
| | - D Taylor
- Mary Bird Perkins Cancer Center, Baton Rouge, LA.,Louisiana State University and A & M College, Baton Rouge, LA.,Rice University, Houston, TX
| | - P Shagin
- Mary Bird Perkins Cancer Center, Baton Rouge, LA.,Louisiana State University and A & M College, Baton Rouge, LA.,Rice University, Houston, TX
| | - E Liang
- Mary Bird Perkins Cancer Center, Baton Rouge, LA.,Louisiana State University and A & M College, Baton Rouge, LA.,Rice University, Houston, TX
| |
Collapse
|
39
|
Salloway S, Sperling R, Keren R, Porsteinsson AP, van Dyck CH, Tariot PN, Gilman S, Arnold D, Abushakra S, Hernandez C, Crans G, Liang E, Quinn G, Bairu M, Pastrak A, Cedarbaum JM. A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease. Neurology 2011; 77:1253-62. [PMID: 21917766 DOI: 10.1212/wnl.0b013e3182309fa5] [Citation(s) in RCA: 174] [Impact Index Per Article: 13.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE This randomized, double-blind, placebo-controlled, dose-ranging phase 2 study explored safety, efficacy, and biomarker effects of ELND005 (an oral amyloid anti-aggregation agent) in mild to moderate Alzheimer disease (AD). METHODS A total of 353 patients were randomized to ELND005 (250, 1,000, or 2,000 mg) or placebo twice daily for 78 weeks. Coprimary endpoints were the Neuropsychological Test Battery (NTB) and Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) scale. The primary analysis compared 250 mg (n =84) to placebo (n =82) after an imbalance of infections and deaths led to early discontinuation of the 2 higher dose groups. RESULTS The 250 mg dose demonstrated acceptable safety. The primary efficacy analysis at 78 weeks revealed no significant differences between the treatment groups on the NTB or ADCS-ADL. Brain ventricular volume showed a small but significant increase in the overall 250 mg group (p =0.049). At the 250 mg dose, scyllo-inositol concentrations increased in CSF and brain and CSF Aβx-42 was decreased significantly compared to placebo (p =0.009). CONCLUSIONS Primary clinical efficacy outcomes were not significant. The safety and CSF biomarker results will guide selection of the optimal dose for future studies, which will target earlier stages of AD. CLASSIFICATION OF EVIDENCE Due to the small sample sizes, this Class II trial provides insufficient evidence to support or refute a benefit of ELND005.
Collapse
Affiliation(s)
- S Salloway
- Neurology and the Memory and Aging Program, Butler Hospital, 345 Blackstone Boulevard, Providence, RI 02906, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
|
41
|
Gong R, Ge Y, Chen S, Liang E, Esparza A, Sabo E, Yango A, Gohh R, Rifai A, Dworkin LD. Glycogen synthase kinase 3beta: a novel marker and modulator of inflammatory injury in chronic renal allograft disease. Am J Transplant 2008; 8:1852-63. [PMID: 18786229 DOI: 10.1111/j.1600-6143.2008.02319.x] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
One key cell-signaling event central to inflammation in kidney diseases, including chronic renal allograft dysfunction or disease (CRAD), is the activation of NF-kappaB, which controls transcription of numerous proinflammatory mediators. Glycogen synthase kinase (GSK) 3beta is an indispensable element of NF-kappaB activation, however, the exact role of GSK3beta in the pathogenesis of inflammatory kidney diseases like CRAD is uncertain and was examined. Immunohistochemistry staining of GSK3beta was weak in normal kidneys, but was markedly induced in inflamed allograft kidneys, with prominent cytoplasmic staining of tubular cells in areas of inflammation. Net GSK3beta activity is regulated by inhibitory phosphorylation of its serine 9 residue, and this occurred in CRAD. Thus, the magnitude of GSK3beta inactivation was inversely correlated with the degree of injury as assessed by Banff criteria. In vitro in cultured human tubular epithelial cells, GSK3beta overexpression augmented, while GSK3beta silencing diminished proinflammatory cellular responses to TNF-alpha stimulation, including NF-kappaB activation and expression of chemokines MCP-1 and RANTES. These inflammatory responses were obliterated by GSK3beta inhibitors. Collectively, GSK3beta plays an important role in mediating proinflammatory NF-kappaB activation and renal inflammation. Suppression of GSK3beta activity might represent a novel therapeutic strategy to treat CRAD.
Collapse
Affiliation(s)
- R Gong
- Division of Kidney Disease and Hypertension, Department of Medicine, Brown University School of Medicine, Providence, RI, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
|
43
|
Ditmire T, Bless S, Dyer G, Edens A, Grigsby W, Hays G, Madison K, Maltsev A, Colvin J, Edwards M, Lee R, Patel P, Price D, Remington B, Sheppherd R, Wootton A, Zweiback J, Liang E, Kielty K. Overview of future directions in high energy-density and high-field science using ultra-intense lasers. Radiat Phys Chem Oxf Engl 1993 2004. [DOI: 10.1016/j.radphyschem.2003.12.042] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
44
|
Liang E, Kabcenell AK, Coleman JR, Robson J, Ruffles R, Yazdanian M. Permeability measurement of macromolecules and assessment of mucosal antigen sampling using in vitro converted M cells. J Pharmacol Toxicol Methods 2001; 46:93-101. [PMID: 12481846 DOI: 10.1016/s1056-8719(02)00163-6] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
INTRODUCTION M cells are located in the epithelial layer covering the gut-associated lymphoid tissue and are responsible for delivery of macromolecules and microorganisms to the underlying lymphoid cells. It has been shown that the human colonic cell line Caco-2 can be converted to M cells in vitro following coculture with isolated lymphocytes from murine Peyer's patches. Studies were undertaken to evaluate and characterize the transepithelial transport of select macromolecules across these in vitro derived M cells. METHODS Caco-2 cells were converted to M cells as reported previously. The morphology of Caco-2 cells and M cells was compared by transmission electron microscopy (TEM). The transport properties of macromolecules such as horseradish peroxidase, FITC-conjugated polystyrene beads, and radiolabeled dextrans were examined. The activation of murine antigen-specific T cells following transport of the antigen ovalbumin across the M-cell barrier was assessed by measuring cytokine production. RESULTS M cells were shown to be irregular in shape and have fewer and shorter microvilli compared to the Caco-2 cell progenitors. These cells were still able to form tight junctions and monolayers on polycarbonate membranes. Time-course studies demonstrated that the transport of polystyrene beads and large-molecular-weight dextrans at physiological temperature across M-cell-containing monolayers was size dependent and more rapid than across Caco-2 cell monolayers. The transport of dextrans was also shown to be temperature and concentration dependent. Befitting the role of the M cell in mucosal defense, protein antigen could be delivered by these cells in order to be processed and presented to antigen-specific CD4+ T lymphocytes. DISCUSSION The M-cell permeability model is a functional and practical system for evaluating the transport properties of macromolecules and assessing the potential for intestinal mucosal antigen sampling to elicit immunological responses.
Collapse
Affiliation(s)
- E Liang
- Pharmaceutics Department, Boehringer Ingelheim Pharmaceuticals, Inc., PO Box 368, 900 Ridgebury Road, Ridgefield, CT 06877, USA
| | | | | | | | | | | |
Collapse
|
45
|
Edwards MJ, MacKinnon AJ, Zweiback J, Shigemori K, Ryutov D, Rubenchik AM, Keilty KA, Liang E, Remington BA, Ditmire T. Investigation of ultrafast laser-driven radiative blast waves. Phys Rev Lett 2001; 87:085004. [PMID: 11497951 DOI: 10.1103/physrevlett.87.085004] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/23/2000] [Indexed: 05/23/2023]
Abstract
We have examined the evolution of cylindrically symmetric blast waves produced by the deposition of femtosecond laser pulses in gas jets. In high- Z gases radiative effects become important. We observe the production of an ionization precursor ahead of the shock front and deceleration parameters below the adiabatic value of 1/2 (for a cylinder), an effect expected when the blast wave loses energy by radiative cooling. Despite significant radiative cooling, the blast waves do not appear to develop thin shell instabilities expected for strongly radiative waves. This is believed to be due to the stabilizing effect of a relatively thick blast wave shell resulting in part from electron thermal conduction effects.
Collapse
Affiliation(s)
- M J Edwards
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Liang E, Proudfoot J, Yazdanian M. Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers. Pharm Res 2000; 17:1168-74. [PMID: 11145220 DOI: 10.1023/a:1026450326712] [Citation(s) in RCA: 70] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
PURPOSE To investigate the mechanisms involved in transport of sulfasalazine in Caco-2 cells. METHODS Permeability coefficients of sulfasalazine and its analogs across Caco-2 cell monolayers were measured as a function of direction of transport, energy and concentration dependence, and in the presence of inhibitors of various cellular efflux pumps and transporters. RESULTS Permeability coefficients of sulfasalazine across Caco-2 cell monolayers were approximately 342-, 261-, and 176-fold higher from basolateral to apical direction (BL-->AP) than from apical to basolateral direction (AP-->BL) at 100, 200, and 500 microM, respectively. Carrier permeability coefficient, non-saturable membrane permeability coefficient, and Michaelis constant were estimated to be 1.4x10(-5) cm/s, 1.9x10(-8) cm/s, and 369 microM, respectively. The efflux of sulfasalazine was completely blocked at 4 degrees C and in the presence of an uncoupler of oxidative phosphorylation. Using cellular efflux inhibitors, the permeability of sulfasalazine was shown to depend on multidrug resistance-associated protein and anion sensitive transport mechanisms. Structure-permeability studies showed that the affinity of sulfasalazine for the cellular efflux pumps and transporters in Caco-2 cells depended strongly on the carboxylic acid functional group. CONCLUSIONS The permeability of sulfasalazine across Caco-2 cell monolayer is very low due to its strong interaction with multiple cellular efflux pumps and transporters. This may partially explain its low absorption in vivo.
Collapse
Affiliation(s)
- E Liang
- Pharmaceutics Department, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT 06877, USA
| | | | | |
Collapse
|
47
|
Liang E, Rosenblatt MN, Ajmani PS, Hughes JA. Biodegradable pH-sensitive surfactants (BPS) in liposome-mediated nucleic acid cellular uptake and distribution. Eur J Pharm Sci 2000; 11:199-205. [PMID: 11042225 DOI: 10.1016/s0928-0987(00)00101-9] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The impact of biodegradable pH-sensitive surfactant (BPS)-liposomes on nucleic acid, i.e., oligonucleotide and plasmid DNA, cellular delivery was examined. Fluorescein-labeled nucleic acids complexed with 1,2-dioleoyl-3-trimethylammonium propane cationic liposomes and BPS at a charge ratio (+/-) of 10 were incubated in CV-1 cells and analyzed by flow cytometry. The fluorescence intensity of oligonucleotides but not plasmid DNA complexed with BPS-liposomes was higher than those complexed with BPS-free liposomes at early time points. However, when cells were fixed to equalize the intracellular pH since fluorescein, a pH-sensitive fluorophore, has higher fluorescence intensity in alkaline pH than acidic, no difference in intensity was observed. This indicated the incorporation of BPS in liposomes did not increase oligonucleotide cellular uptake over control liposomes, but redistributed oligonucleotides into a more basic environment, e.g., cytoplasm. An explanation consistent with the presented data is the formation of small transient membrane defects within the endosomal membrane as presented previously [Liang, E., Hughes, J.A., 1998a. Membrane fusion and rupture in liposomes: effect of biodegradable pH-sensitive surfactants. J. Membr. Biol. 166, 37-49.]. The above findings suggested that BPS may be effective agents of disrupting one of the major barriers, endosomal membrane, to enhance nucleic acid cellular transport.
Collapse
Affiliation(s)
- E Liang
- Department of Pharmaceutics, College of Pharmacy, University of Florida, P.O. Box 100494, Gainesville, FL 32610, USA
| | | | | | | |
Collapse
|
48
|
Shigemori K, Ditmire T, Remington BA, Yanovsky V, Ryutov D, Estabrook KG, Edwards MJ, MacKinnon AJ, Rubenchik AM, Keilty KA, Liang E. Developing a Radiative Shock Experiment Relevant to Astrophysics. Astrophys J 2000; 533:L159-L162. [PMID: 10770714 DOI: 10.1086/312621] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/25/2000] [Accepted: 03/08/2000] [Indexed: 05/23/2023]
Abstract
We report on the initial results of experiments being developed on the Falcon laser to simulate radiative astrophysical shocks. Cylindrically diverging blast waves were produced in low-density ( approximately 1018 cm-3), high-Z gas by laser-irradiating Xe gas jets containing atomic clusters. The blast-wave trajectory was measured by Michelson interferometry. The velocity for the blast wave is slightly less than the adiabatic Sedov-Taylor prediction, and an ionization precursor is observed ahead of the shock front. This suggests energy loss through radiative cooling and reduced compression due to preheat deposited ahead of the shock, both consistent with one-dimensional radiation hydrodynamics simulations.
Collapse
|
49
|
Abstract
An accelerated 3-7-day Caco-2 cell permeability model was examined and compared to the traditional 21-25-day model. Caco-2 cell permeability coefficients (P(Caco-2)) of 33 structurally diverse small molecular weight compounds from apical to basolateral (AP-->BL) direction in the accelerated model were approximately twice those in the traditional model. As observed with microscopy and transepithelial electrical resistance measurements, this difference was attributed to less confluent and differentiated Caco-2 cell monolayers in the accelerated model. However, there were no significant differences in rank ordering of the compounds. The expression of P-glycoprotein in the accelerated model was shown to be significantly less than that in the traditional model. This resulted in lower permeability directional ratios defined as the ratio between permeability coefficients from BL-->AP and from AP-->BL for compounds that were cellular efflux pump substrates. The accelerated model may not be suitable for studying cellular efflux pumps such as P-glycoproteins. However, it is a feasible alternative to the traditional model for rank ordering of compounds in the process of drug discovery and development by significantly improving the turnover time and labor efficiency. This makes it an excellent Caco-2 cell permeability model for high throughput screening.
Collapse
Affiliation(s)
- E Liang
- Pharmaceutics Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, P.O. Box 368, Ridgefield, Connecticut 06877, USA
| | | | | |
Collapse
|
50
|
Abstract
A variety of techniques are currently available to enhance the cellular uptake and pharmacological effectiveness of antisense oligonucleotides in the in vitro setting. The choice of technique will depend on the context of investigation, the likelihood of cytotoxity due to the delivery agents, and the ease and convenience of the approach. The considerations for the delivery of antisense molecules in the in vivo setting are likely to be quite different from the cell culture situation emphasized in this article.
Collapse
Affiliation(s)
- J Hughes
- Department of Pharmaceutics, University of Florida, Gainesville 32610, USA
| | | | | | | | | | | | | | | |
Collapse
|